Tate & Lyle PLC shares climbed strongly in London trading after Ingredion Incorporated made a formal recommended all-cash proposal to buy the UK specialty ingredients company for a total consideration of up to 615 pence per share. The package comprises 595 pence in cash and up to 20 pence in dividends, giving a headline transaction valuation of 2.7 billion.
The market reaction pushed Tate & Lyle stock up by 12.1% to trade at 551p on the day of the announcement. Under the terms set out by Ingredion, Tate & Lyle shareholders would receive 595 pence per share in cash, which the bidder says equates to a 59% premium to Tate & Lyles closing share price on May 13, 2026.
Shareholders would also be entitled to collect a final dividend of no greater than 13.2 pence per share for the financial year ended March 31, 2026, and an interim dividend of no greater than 6.8 pence per share for the six-month period ending September 30, 2026. Those dividend entitlements account for the additional up to 20 pence per share that, when combined with the cash element, bring the total potential consideration to 615 pence per share.
The approach from Ingredion had been signalled in advance: reports indicated the US company had been in advanced talks and was aiming to announce an agreement as soon as Monday. In its formal proposal, Ingredion said it had obtained an irrevocable undertaking from Huber Equity Corporation to vote in favour of the scheme in respect of 75 million Tate & Lyle shares, representing approximately 16.8% of the company's issued ordinary share capital as of June 5, 2026.
Ingredion outlined its intended funding plan for the acquisition, which includes the use of existing cash resources, new debt financing, and a fully committed bridge financing facility. The company said pro forma net leverage at completion is expected to be approximately 3.0x net debt-to-adjusted EBITDA, with a plan to reduce leverage to about 2.5x within 18 months.
The proposed transaction will be implemented by way of a court-sanctioned scheme of arrangement under the United Kingdom Companies Act 2006. Completion is conditional on shareholder approval, court sanction and applicable antitrust clearances; Ingredion indicated it expects the deal to complete in the second half of 2027.
The bid and the market's response stood out against a weaker UK market backdrop. The FTSE 100 fell 0.27% on the day, with the session affected by a risk-off tone across global equities and by direct hostilities between Iran and Israel for the first time since April's ceasefire, an escalation that coincided with the 100th day of the Iran conflict.
Market observers noted that the combination of a sizable takeover premium, a unanimous recommendation from Tate & Lyle's board and a major shareholder's binding support created a confluence of drivers behind the share price rally. Nonetheless, with shares trading at 551p - still below the 595p cash component of the bid - investors appear to be applying a modest completion discount, reflecting remaining regulatory and timing uncertainties.
Details at a glance
- Offer structure: 595p cash plus up to 20p in dividends (up to 615p per share)
- Headline value: 2.7 billion
- Premium: 59% to Tate & Lyle's closing price on May 13, 2026
- Shareholder support: irrevocable undertaking from Huber Equity Corporation for ~75 million shares (approx. 16.8% as of June 5, 2026)
- Financing: existing cash, new debt and a fully committed bridge facility; expected pro forma net leverage ~3.0x, with reduction target to ~2.5x within 18 months
- Implementation: scheme of arrangement under the UK Companies Act 2006; subject to shareholder, court and antitrust approvals; expected completion H2 2027